Sign Up to like & get
recommendations!
0
Published in 2019 at "World neurosurgery"
DOI: 10.1016/j.wneu.2018.11.011
Abstract: BACKGROUND Pituitary carcinomas are rare and aggressive neoplasms that despite current treatment regimens continue to have a poor prognosis. Adrenocorticotrophic hormone pituitary tumors have been shown to alter their clinical manifestations with conversion to Cushing…
read more here.
Keywords:
hormone;
silent corticotroph;
hormone secreting;
secreting pituitary ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Laboratory medicine"
DOI: 10.1093/labmed/lmab053
Abstract: Silent corticotroph adenoma (SCA) is as an aggressive pituitary tumor. A 48 year old man developed hypogonadotrophic hypogonadism. The basal morning adrenocorticotropic hormone (ACTH) was elevated, but the basal morning and peak after ACTH (1-24)…
read more here.
Keywords:
silent corticotroph;
corticotroph adenoma;
adrenocorticotropic hormone;
acth ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "European journal of endocrinology"
DOI: 10.1530/eje-21-1183
Abstract: OBJECTIVE Provide insights into the defective POMC processing and invasive behavior in silent pituitary corticotroph tumors. DESIGN AND METHODS Single cell RNAseq was used to compare the cellular makeup and transcriptome of silent and active…
read more here.
Keywords:
cell;
corticotroph tumors;
corticotroph;
silent corticotroph ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.863017
Abstract: Ubiquitination is reported to be a critical biological event on ACTH secretion in corticotroph adenomas. However, the effect of ubiquitylation on ACTH secretion in silent corticotroph adenomas (SCAs) remains unclear. The aim of our study…
read more here.
Keywords:
ubiquitinated proteins;
corticotroph adenomas;
secretion;
silent corticotroph ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.870172
Abstract: Clinically silent corticotroph tumors are usually macroadenomas that comprise 20% of ACTH tumors. They frequently progress to aggressive tumors with high recurrence, invasiveness, and on rare occasions, they may become hormonally active causing Cushing’s disease.…
read more here.
Keywords:
corticotroph tumor;
tumor;
catenin;
pathology ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1124646
Abstract: Objective Pituitary neuroendocrine corticotroph tumors commonly cause Cushing’s disease (CD) that results from increased adrenocorticotropic hormone (ACTH) secretion by the pituitary tumor and consequent increase of cortisol levels in blood. However, in some patients, corticotroph…
read more here.
Keywords:
glucocorticoid mineralocorticoid;
expression;
corticotroph tumors;
silent corticotroph ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13236134
Abstract: Simple Summary The 2017 World Health Organization classification of endocrine tumors defines pituitary adenomas based on their cell lineages. T-PIT can serve as a complimentary tool for further identification of silent corticotroph adenomas (SCAs). Unlike…
read more here.
Keywords:
silent corticotroph;
clinical features;
corticotroph adenomas;
scas ... See more keywords